Research and Markets: United States Anti Cancer Drug Market Outlook to 2018 - Demand of Oral Drugs to Drive Growth

Research and Markets (http://www.researchandmarkets.com/research/csjfd9/the_us_anti) has announced the addition of the "The US Anti Cancer Drug Market Outlook to 2018 - Demand of Oral Drugs to Drive Growth" report to their offering.

The report titled "The US Anti Cancer Drug Market Outlook to 2018 - Demand of Oral Drugs to Drive Growth" provides a comprehensive analysis on the Anti Cancer Drug market in the US covering various aspects such as market size of the industry, market segmentation by Patented and Generic drugs, by type of cancer (blood cancer, breast cancer, lung cancer, pancreatic cancer, colon cancer) and by Oral and Injectable Drugs.

The report also provides statistics and information on the government regulations, growth drivers and market shares of major players and brands in the market. The report also entails competitive landscape and profiles of the major players operating in the market. The future projections are included to provide an insight on the prospects in the US Anti Cancer Drug Market.

Key Topics Covered In The Report:

• The market size of the US anti cancer drug market on the basis of sales, number of drugs in development and number of drugs approved.
• The breast cancer, lung cancer, pancreatic cancer, colon cancer, blood and brain cancer drug market
• Market segmentation of the US anti cancer drug market on the basis of Type of Therapies, Orals and Injectables and by Generic and Patented Drugs
• Government Regulations in the US Anti Cancer Drug Market.
• Competitive landscape and detailed company profiles of the major players operating in the pesticides business in US
• Revenues of Major Players in US Anti Cancer Drugs Market.
• Future outlook and projections of US Anti Cancer Drugs Market, on the basis of anti cancer drug sales in the US.

Key Topics Covered:

1. Anti-Cancer Drugs Market Introduction

2. Prevalence of Different types of Cancers in the US

4. The US Anti-cancer Drug Market Segmentation

5. The US Blood Cancer Drug Market Introduction

6. The US Breast Cancer Drugs Market Introduction

7. The US Colon Cancer Drugs Market Introduction

8. The US Brain Cancer Drugs Market Introduction

9. The US Lung Cancer Drugs Market Introduction

10. The US Pancreatic Cancer Drugs Market Introduction

11. Trends and Developments

12. Regulations in the US Anti-cancer Drug Market

13. SWOT Analysis

14. Growth Drivers and Restraints

15. The US Anti-Cancer Drugs Industry Competitive Landscape

16. Company Profiles

17. The US Anti-Cancer Drug Market Future Outlook

18. Macro-Economic Factors Affecting the US Anti-Cancer Drugs Market

19. Appendix

Companies Mentioned

• Amgen
• Astra Zeneca
• Bristol Myers
• Celgene
• Eli Lilly
• GlaxoSmithKline
• Merck & Co
• Novartis
• Pfizer
• Roche
• Sanofi Aventis

For more information visit http://www.researchandmarkets.com/research/csjfd9/the_us_anti